CommentaryPolicy

Reengineering Translational Science: The Time Is Right

Science Translational Medicine  06 Jul 2011:
Vol. 3, Issue 90, pp. 90cm17
DOI: 10.1126/scitranslmed.3002747

You are currently viewing the abstract.

View Full Text

Abstract

Despite dramatic advances in the molecular pathogenesis of disease, translation of basic biomedical research into safe and effective clinical applications remains a slow, expensive, and failure-prone endeavor. To pursue opportunities for disruptive translational innovation, the U.S. National Institutes of Health (NIH) intends to establish a new entity, the National Center for Advancing Translational Sciences (NCATS). The mission of NCATS is to catalyze the generation of innovative methods and technologies that will enhance the development, testing, and implementation of diagnostics and therapeutics across a wide range of diseases and conditions. The new center’s activities will complement, and not compete with, translational research being carried out at NIH and elsewhere in the public and private sectors.

Footnotes

  • Citation: F. S. Collins, Reengineering translational science: The time is right. Sci. Transl. Med. 3, 90cm17 (2011).

View Full Text